Experts recently debated whether additional intensive therapy can improve posttransplant outcomes for patients with acute myeloid leukemia who have residual disease after induction therapy.
Pediatric patients receiving a donor stem cell transplant who have healthier pretransplant gut microbiota diversity show improved rates of survival and a lower risk of acute GvHD.
It s difficult to know whether the girl s death was directly related to her socioeconomic status, but it certainly made all aspects of the child s care more complicated.
Adding quizartinib to standard induction chemotherapy significantly improves overall survival in patients with newly diagnosed acute myeloid leukemia regardless of prior stem cell transplantation.